Liver Cirrhosis, Experimental - Metabolism
Research News and Information

Sunday, November 22, 2009

Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis.

26 Sep 2009 AIM: To investigate the inhibitory effect of natural taurine (NTau) on portal hypertension (PHT) in rats with experimentally-induced liver cirrhosis (LC). METHODS: Experimentally-induced LC Wistar rats (20 rats/group) were treated with either oral ... Read more...

PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis.

30 Aug 2009 The gene phosphatase and tensin homolog deleted on chromosome 10 (PTEN) codes for a tumor-suppressor phospholipid phosphatase. Deletion, mutation or abnormal expression of PTEN is commonly found in many kinds of malignant tumors. At the time of this ... Read more...

Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice.

27 Jul 2009 BACKGROUND & AIMS: Recent studies have reported that bone marrow (BM)-derived cells migrating into fibrotic liver tissue exhibit a myofibroblast-like phenotype and may participate in the progression of liver fibrosis. However, their contribution to ... Read more...

Latest indexed articles for 'Liver Cirrhosis, Experimental - Metabolism'

These are the very latest articles for this heading:

• Attenuation of portal hypertension by natural taurine in rats with liver cirrhosis. 26 Sep 2009
• PTEN expression is down-regulated in liver tissues of rats with hepatic fibrosis induced by biliary stenosis. 30 Aug 2009
• The bone marrow and liver fibrosis: friend or foe? 27 Aug 2009
• Negligible contribution of bone marrow-derived cells to collagen production during hepatic fibrogenesis in mice. 27 Jul 2009
• Hedgehog-mediated epithelial-to-mesenchymal transition and fibrogenic repair in nonalcoholic fatty liver disease. Jul 2009
• Adenosine triphosphate-binding cassette subfamily C member 2 is the major transporter of the hepatobiliary imaging agent (99m)Tc-mebrofenin. 10 Jun 2009
• Loss of steroid receptor co-activator-3 attenuates carbon tetrachloride-induced murine hepatic injury and fibrosis. 30 May 2009
• Accelerative effect of leflunomide on recovery from hepatic fibrosis involves TRAIL-mediated hepatic stellate cell apoptosis. 8 Apr 2009
• Morphological changes of rat astrocytes induced by liver damage but not by manganese chloride exposure. 6 Apr 2009
• Liver growth factor antifibrotic activity in vivo is associated with a decrease in activation of hepatic stellate cells. 30 Mar 2009
• Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate. 21 Mar 2009
• Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. 17 Mar 2009
• Pharmacokinetics of oltipraz in diabetic rats with liver cirrhosis. 27 Feb 2009
• The protective effects of a fermented substance from Saccharomyces cerevisiae on carbon tetrachloride-induced liver damage in rats. 21 Feb 2009
• [Effects of bone morphogenic proteins-7 on production of collagen from hepatocytes and hepatic stellate cells during liver fibrosis] 15 Feb 2009
• Retinoid metabolism in the small intestine during development of liver cirrhosis. 13 Feb 2009
• Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. 12 Jan 2009
• Paraoxonase-1 is related to inflammation, fibrosis and PPAR delta in experimental liver disease. 12 Jan 2009
• [Interrelation between the glycogen content in hepatocytes and their size in normal and cirrhotic rat liver] 30 Dec 2008
• Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats. 15 Dec 2008

See a longer list of these articles.

Technical information about 'Liver Cirrhosis, Experimental'

Definition: Experimentally induced chronic injuries to the parenchymal cells in the liver to achieve a model for LIVER CIRRHOSIS.

Descriptor UI: D008106

Alternative terms: Liver Cirrhosis, Experimental; Cirrhosis, Experimental Liver; Liver Cirrhoses, Experimental; Experimental Liver Cirrhosis; Hepatic Cirrhosis, Experimental; Experimental Hepatic Cirrhosis; Cirrhoses, Experimental Liver; Experimental Liver Cirrhoses;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C06.552.630.467; E05.598.500.468;

Technical Notes: DF: LIVER CIRRHOSIS EXPER